Integrated BioPharma, Inc. (INBP)
0.175
0.00 (0.00%)
USD |
OTCM |
Oct 23, 16:00
Integrated BioPharma Enterprise Value : 4.042M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.042M |
| October 22, 2026 | 4.042M |
| October 21, 2026 | 4.042M |
| October 20, 2026 | 4.198M |
| October 19, 2026 | 4.198M |
| October 16, 2026 | 4.198M |
| October 15, 2026 | 4.198M |
| October 14, 2026 | 4.271M |
| October 13, 2026 | 4.271M |
| October 12, 2026 | 4.275M |
| October 09, 2026 | 4.477M |
| October 08, 2026 | 4.353M |
| October 07, 2026 | 4.477M |
| October 06, 2026 | 4.353M |
| October 05, 2026 | 3.887M |
| October 02, 2026 | 4.260M |
| October 01, 2026 | 4.260M |
| September 30, 2026 | 3.580M |
| September 29, 2026 | 3.887M |
| September 28, 2026 | 3.887M |
| September 25, 2026 | 4.313M |
| September 24, 2026 | 4.353M |
| September 23, 2026 | 4.353M |
| September 22, 2026 | 4.344M |
| September 21, 2026 | 4.263M |
| Date | Value |
|---|---|
| September 18, 2026 | 3.626M |
| September 17, 2026 | 4.041M |
| September 16, 2026 | 3.887M |
| September 15, 2026 | 4.136M |
| September 14, 2026 | 3.887M |
| September 11, 2026 | 3.887M |
| September 10, 2026 | 4.198M |
| September 09, 2026 | 4.198M |
| September 08, 2026 | 4.198M |
| September 04, 2026 | 4.198M |
| September 03, 2026 | 4.198M |
| September 02, 2026 | 4.198M |
| September 01, 2026 | 4.198M |
| August 31, 2026 | 4.508M |
| August 28, 2026 | 4.198M |
| August 27, 2026 | 4.476M |
| August 26, 2026 | 4.042M |
| August 25, 2026 | 4.010M |
| August 24, 2026 | 3.794M |
| August 21, 2026 | 4.198M |
| August 20, 2026 | 4.138M |
| August 19, 2026 | 4.138M |
| August 18, 2026 | 4.175M |
| August 17, 2026 | 3.576M |
| August 14, 2026 | 3.824M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Medifast, Inc. | -9.484M |
| BioForce Nanosciences Holdings, Inc. | 259.67M |
| Skinvisible, Inc. | 6.703M |
| SkyTech Orion Global Corp. | 11.04M |
| Nevis Brands, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.366M |
| Revenue (Quarterly) | 9.796M |
| Total Expenses (Quarterly) | 11.16M |
| EPS Diluted (Quarterly) | -0.044 |
| Gross Profit Margin (Quarterly) | 0.29% |
| Profit Margin (Quarterly) | -13.94% |
| Earnings Yield | -52.34% |
| Normalized Earnings Yield | -52.29 |